NEW YORK (360Dx) – The US Food and Drug Administration today released a draft guidance intended to update and provide clarity for its staff and for manufacturers of in vitro diagnostic devices about its re
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.